| The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma A Rosenwald, G Wright, WC Chan, JM Connors, E Campo, RI Fisher, ... New England Journal of Medicine 346 (25), 1937-1947, 2002 | 4874 | 2002 |
| Optimal two-stage designs for phase II clinical trials R Simon Controlled clinical trials 10 (1), 1-10, 1989 | 3986 | 1989 |
| Flexible regression models with cubic splines S Durrleman, R Simon Statistics in medicine 8 (5), 551-561, 1989 | 2701 | 1989 |
| Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial SJ Pocock, R Simon Biometrics, 103-115, 1975 | 2610 | 1975 |
| Molecular classification of cutaneous malignant melanoma by gene expression profiling M Bittner, P Meltzer, Y Chen, Y Jiang, E Seftor, M Hendrix, M Radmacher, ... Nature 406 (6795), 536-540, 2000 | 2604 | 2000 |
| Gene-expression profiles in hereditary breast cancer I Hedenfalk, D Duggan, Y Chen, M Radmacher, M Bittner, R Simon, ... New England Journal of Medicine 344 (8), 539-548, 2001 | 2182 | 2001 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2166 | 1998 |
| Bias in error estimation when using cross-validation for model selection S Varma, R Simon BMC bioinformatics 7, 1-8, 2006 | 1946 | 2006 |
| Comparison of MR/ultrasound fusion–guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer MM Siddiqui, S Rais-Bahrami, B Turkbey, AK George, J Rothwax, ... Jama 313 (4), 390-397, 2015 | 1747 | 2015 |
| Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells SS Dave, G Wright, B Tan, A Rosenwald, RD Gascoyne, WC Chan, ... New England Journal of Medicine 351 (21), 2159-2169, 2004 | 1674 | 2004 |
| Prediction error estimation: a comparison of resampling methods AM Molinaro, R Simon, RM Pfeiffer Bioinformatics 21 (15), 3301-3307, 2005 | 1599 | 2005 |
| Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia A Rosenwald, AA Alizadeh, G Widhopf, R Simon, RE Davis, X Yu, L Yang, ... The Journal of experimental medicine 194 (11), 1639-1648, 2001 | 1462 | 2001 |
| Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma A Rosenwald, G Wright, K Leroy, X Yu, P Gaulard, RD Gascoyne, ... The Journal of experimental medicine 198 (6), 851-862, 2003 | 1370 | 2003 |
| Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification R Simon, MD Radmacher, K Dobbin, LM McShane Journal of the National Cancer Institute 95 (1), 14-18, 2003 | 1214 | 2003 |
| Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. M Smith, D Arthur, B Camitta, AJ Carroll, W Crist, P Gaynon, R Gelber, ... Journal of Clinical Oncology 14 (1), 18-24, 1996 | 1203 | 1996 |
| Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines LV Rubinstein, RH Shoemaker, KD Paull, RM Simon, S Tosini, P Skehan, ... JNCI: Journal of the National Cancer Institute 82 (13), 1113-1117, 1990 | 1177 | 1990 |
| Use of archived specimens in evaluation of prognostic and predictive biomarkers RM Simon, S Paik, DF Hayes Journal of the National Cancer Institute 101 (21), 1446-1452, 2009 | 1144 | 2009 |
| The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma A Rosenwald, G Wright, A Wiestner, WC Chan, JM Connors, E Campo, ... Cancer cell 3 (2), 185-197, 2003 | 1099 | 2003 |
| Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning QH Ye, LX Qin, M Forgues, P He, JW Kim, AC Peng, R Simon, Y Li, ... Nature medicine 9 (4), 416-423, 2003 | 1096 | 2003 |
| SYSTEMIC TREATMENT OF EARLY BREAST-CANCER BY HORMONAL, CYTOTOXIC, OR IMMUNE THERAPY-133 RANDOMIZED TRIALS INVOLVING 31000 RECURRENCES AND 24000 DEATHS AMONG 75000 WOMEN. 2. O Abe, R Abe, K Asaishi, K Enomoto, T Hattori, Y Ino, K Kikuchi, ... Lancet 339 (8785), 71-85, 1992 | 1087 | 1992 |
